B-FLEXION
Investment Details
Investor Type
Family Office
Asset Class Focus
Private Equity, Venture Capital, Infrastructure, Technology, Real Estate, Hedge Funds, Public and Private Credit, Public Securities
Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Switzerland, Ireland, Jersey
Industries Focus
- Technology
- Real Estate
- Life Sciences
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Hedge Funds
- Medical Research
- Healthcare IT
- Public Securities
- Public and Private Credit
Investor Details Founded: 2012
B-FLEXION is a private, entrepreneurial investment firm headquartered in Geneva, Switzerland. The firm manages the Bertarelli family's wealth, investing through various specialist investment partnerships across sectors such as real estate, technology, hedge funds, and life sciences. B-FLEXION operates offices in Geneva, London, Jersey, Boston, and Dublin, deploying patient capital alongside aligned institutional and family partners.
The firm's investment strategy focuses on building long-term value by partnering with asset managers and operating businesses. B-FLEXION allocates capital to both established and emerging opportunities, primarily in life sciences, healthcare services, and digital health. The firm has a history of active investments, including leading growth-stage rounds through its venture arm, Forestay Capital, and achieving significant exits in the healthcare sector.
B-FLEXION's portfolio includes investments in companies such as efimosfermin, Paratek Pharmaceuticals, Buynomics, and Datavations. The firm has a track record of deploying capital across various sectors and geographies, with a focus on transformative industries. B-FLEXION's approach combines entrepreneurial spirit with a commitment to delivering exceptional value over generations, while contributing positively to society.
Requirements
- Sophisticated capital partners
- Alignment with family interests and strategic objectives
- Focus on long-term value creation
- Interest in life sciences, healthcare services, and digital health sectors
- Willingness to engage in both established and emerging opportunities
- Commitment to transformative industries
- Openness to patient capital deployment
- Alignment with institutional and family partners
- Interest in global investment opportunities
- Focus on building operating businesses
- Willingness to partner with asset managers
- Interest in diverse asset classes
- Commitment to positive societal impact
- Alignment with B-FLEXION's heritage and values
- Interest in both private and public market investments
- Willingness to engage in complex transactions
- Interest in high-quality assets with limited competition
- Openness to innovative and structured solutions
- Alignment with B-FLEXION's strategic objectives
- Commitment to deploying capital across various sectors and geographies
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- efimosfermin
- Paratek Pharmaceuticals
- Buynomics
- Datavations
Claim this Investor
Are you an official representative of B-FLEXION?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim